Skip to content

Who We Are

We are a next-generation eye care distribution and technology company, combining decades of leadership experience in consumer goods with advanced AI capabilities. Our team has a proven track record of building global brands and scaling businesses across Europe, the Middle East, and Africa. By partnering with industry leaders such as Johnson & Johnson Vision, Alcon, Bausch + Lomb, and CooperVision, we operate at the intersection of healthcare, technology, and consumer experience.

What We Do & How We Are Different

We connect leading global eye care brands with consumers through a seamless, data-driven distribution model. Beyond traditional distribution, we leverage AI-powered insights to personalize product recommendations, optimize pricing and promotions, and enhance the end-to-end customer journey. What sets us apart is our unique combination of FMCG brand-building expertise and advanced technology, enabling us not only to distribute products, but to actively create demand, improve conversion, and build a smarter, more responsive marketplace for vision care.

Why It Matters

Better vision impacts quality of life, productivity, and long-term health, yet access to the right eye care solutions remains fragmented and complex. We simplify this by making trusted, high-quality products more accessible, personalized, and easy to choose. For our partners, we unlock growth through smarter distribution and deeper consumer engagement; for customers, we deliver a more relevant and convenient experience.

Roman Melesh

Roman Melesh
CEO

LinkedIn
Rostyslav Sulym

Rostyslav Sulym
COO & CIO

LinkedIn
50K+ Prescriptions Analyzed
4 Global Partners
15+ Countries Served
99.2% Accuracy Rate

Trusted by the World's Leading Lens Manufacturers

We work directly with global industry leaders to deliver premium contact lens solutions powered by AI diagnostics.

Frequently Asked Questions

Our proprietary AI models are trained on 50,000+ successful prescriptions, achieving 99.2% diagnostic accuracy. We combine real-time topography analysis with partnerships from the world's top lens manufacturers.

Our first-fit success rate exceeds 90%, with an overall diagnostic accuracy of 99.2%. Each recommendation is cross-validated against clinical data from Johnson & Johnson Vision, Alcon, Bausch+Lomb, and CooperVision.

Absolutely. All data is processed with end-to-end encryption and stored in GDPR-compliant infrastructure. We never share personal health data with third parties.

R2 Trading AI currently operates in over 15 countries across Europe, the Middle East, and North America. We're expanding to additional markets in 2026.

Scroll to Top